Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response
暂无分享,去创建一个
D. Mukhopadhyay | A. Mazar | A. Kozikowski | S. Dutta | E. Wang | F. Giles | Jin-San Zhang | D. Billadeau | A. Ugolkov | L. Ding | Spencer Kiers | Yu Zhang | D. Schmitt | O. Alekhina | V. Madamsetty | J. Dube | E. Wang